Related Experiment Videos
Osteoblast-specific factor 2 reduces glutathione by downregulating PRKRA expression in oral squamous cell carcinoma
Binbin Yu1,2, Shimin Zhao1,2, Jun Wang1,2
1Department of Pediatric Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, Shanghai, China.
Background:
Glutathione (GSH) has been increasingly implicated in tumor progression. This study aimed to investigate the role of GSH in oral squamous cell carcinoma (OSCC) and to characterize how its metabolism is modulated.
Methods:
Following treatment with osteoblast-specific factor 2 (OSF-2, POSTN), HN6 cells were subjected to RNA sequencing, metabolomics analysis and protein mass spectrometry. Then the levels of GSH, glutathione disulfide (GSSG) and reactive oxygen species (ROS) were measured. Western blot analysis was employed to determine the expression of PRKRA in recombinant human POSTN (rhPOSTN)-treated HN6 cells. Statistical analysis was performed using SPSS 19.0 and P<0.05 was considered to be statistically significant.
Results:
Following rhPOSTN treatment, the GSH expression levels were significantly reduced, while the GSSG and ROS levels were significantly increased. Similarly, PRKRA expression was also significantly decreased. Overexpression of PRKRA markedly elevated the GSH levels and reduced the GSSG and ROS levels in OSCC cells. However, this effect was reversed by rhPOSTN. Finally, multiple pathways were implicated in POSTN-induced GSH reduction, of which the first three were apoptotic signaling, Wnt signaling and I-kappaB kinase/NF-kappaB signaling pathways.
Conclusions:
Collectively, these findings indicate that POSTN reduced GSH levels through downregulating PRKRA, suggesting that GSH may serve as a potential therapeutic target in OSCC, thereby informing novel strategies for cancer intervention.
Insights
Osteoblast-specific factor 2 (POSTN) reduces glutathione (GSH) levels in oral squamous cell carcinoma (OSCC) by downregulating PRKRA. This suggests GSH is a potential therapeutic target for OSCC intervention.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glutathione (GSH) plays a role in tumor progression.
- Oral squamous cell carcinoma (OSCC) is a significant oral cancer.
- Understanding GSH metabolism in OSCC is crucial for therapeutic development.
Purpose of the Study:
- Investigate the role of GSH in OSCC.
- Characterize the modulation of GSH metabolism in OSCC.
- Determine the effect of osteoblast-specific factor 2 (POSTN) on GSH levels and related pathways in OSCC.
Main Methods:
- Utilized RNA sequencing, metabolomics, and protein mass spectrometry on HN6 cells treated with POSTN.
- Measured levels of GSH, glutathione disulfide (GSSG), and reactive oxygen species (ROS).
- Assessed PRKRA expression via Western blot analysis and performed statistical analysis.
Main Results:
- POSTN treatment significantly reduced GSH levels while increasing GSSG and ROS levels in OSCC cells.
- PRKRA expression was significantly decreased following POSTN treatment.
- Overexpression of PRKRA increased GSH and decreased GSSG/ROS, an effect reversed by POSTN.
Conclusions:
- POSTN reduces GSH levels in OSCC by downregulating PRKRA.
- GSH modulation represents a potential therapeutic strategy for OSCC.
- Findings inform novel cancer intervention strategies targeting GSH metabolism.
Related Concept Videos
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...